Stockscreener 앱 받기
1.32
0.75%
-0.01
Inmed Pharmaceuticals Inc (INM) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Operating Expenses |
24.17%
2.8395
|
2.2868 | 2.2238 | 2.3967 | 2.3131 |
| Depreciation and Amortization |
2.81%
0.0517
|
0.0532 | 0.0532 | 0.0528 | 0.0523 |
| Income/Loss From Continuing Operations Before Tax |
37.65%
-2.7918
|
-2.0282 | -1.7269 | -1.7883 | -2.1209 |
| Income/Loss From Continuing Operations After Tax |
37.65%
-2.7918
|
-2.0282 | -1.7269 | -1.7883 | -2.1209 |
| Income/Loss From Discontinued Operations, Net Of Tax |
-0.1746
|
- | - | - | - |
| Net Income/Loss |
46.25%
-2.9663
|
-2.0282 | -1.7269 | -1.7883 | -2.1209 |
| Basic Average Shares |
2.37%
4.0482
|
3.9545 | 3.9545 | 0.1721 | 1.096 |
| Diluted Average Shares |
2.37%
4.0482
|
3.9545 | 3.9545 | 0.1721 | 1.096 |
| Basic Earnings Per Share |
43.14%
-0.73
|
-0.51 | -0.44 | -0.43 | -1.94 |
| Diluted Earnings Per Share |
43.14%
-0.73
|
-0.51 | -0.44 | -0.43 | -1.94 |
7.97%
3.58%
자본화:
|
볼륨(24시간):